NASDAQ · Key Statistics

Repligen Corporation (RGEN) P/E Ratio, ROE & Key Statistics

$162.18 NASDAQ: RGEN Market Cap $10.37B

Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Repligen Corporation (RGEN), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

MetricValue
P/E ratioShare price divided by earnings per share.-839.05
P/B ratioShare price divided by book value per share.4.76
P/S ratioMarket value divided by annual revenue.13.89

Profitability

MetricValue
Operating marginRevenue left after operating costs.8.13%
Net marginRevenue left after every cost, including tax and interest.6.64%
Return on equityProfit as a percentage of shareholders’ equity.2.33%
Return on assetsProfit as a percentage of total assets.1.66%
Return on capital employedOperating profit against the capital the business uses.2.13%

Financial health

MetricValue
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.8.36
Quick ratioThe same, excluding inventory.7.11
Cash ratioCash alone against current liabilities.4.16
Debt to equityTotal borrowings against shareholders’ equity.0.33
Debt to assetsTotal borrowings against total assets.0.23
Interest coverageHow many times operating profit covers the interest bill.2.61

Per share and size

MetricValue
Earnings per shareProfit attributable to each share.$0.86
Market capitalisationShare price times shares outstanding.$10.37B

Dividend

MetricValue
Dividend yieldAnnual dividend as a percentage of the share price.0.00%

Repligen Corporation (RGEN) statistics — frequently asked questions

What is Repligen Corporation's P/E ratio?

Repligen Corporation (RGEN) trades on a price-to-earnings ratio of -839.05. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Repligen Corporation's return on equity?

Repligen Corporation (RGEN) reports a return on equity of 2.33%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Repligen Corporation carry?

Repligen Corporation (RGEN) has a debt-to-equity ratio of 0.33, which compares total borrowings with shareholders' equity.

What is Repligen Corporation's profit margin?

Repligen Corporation (RGEN) keeps 6.64% of revenue as net profit after every cost, including tax and interest.

P/E and ROE of other Medical - Instruments & Supplies stocks

BDX P/E 50.89MDLN P/E 62.75WST P/E 45.37SOLV P/E 99.57BAX ROE -16.60%COO P/E 20.32AVTR P/E 31.15ATR P/E 34.46BLCO ROE -1.73%TFX P/E 18.79All Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.